Results 141 to 150 of about 254,699 (197)

Refractory autoimmune hemolytic anemia with poor erythropoietic compensation in combined immunodeficiency: A case series. [PDF]

Pediatr Allergy Immunol
Baldini L, Moratti M, Ruggi A, Licciardi F, Melchionda F, Fois M, Cantarini ME, Facchini E, Barat V, Borrello GD, Fattizzo B, Sabattini E, Bertuzzi C, Masetti R, Conti F.   +14 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Safety of Intravenous Immunoglobulin

Archives of Neurology, 1993
The current position of intravenous immunoglobulin (IVIG) in neurology is similar to that of plasmapheresis 10 years ago. Therapeutic claims have been made for an increasing number of neurologic disorders, based on small, uncontrolled studies. With the recent publication of a controlled trial of IVIG treatment in Guillain-Barre syndrome, 1 and trials ...
C A, Thornton, M, Ballow
openaire   +2 more sources

Intravenous Immunoglobulin and Atherosclerosis

Clinical Reviews in Allergy & Immunology, 2005
Several inflammatory and immunological factors have been established as important contributors to atherogenesis. Among these, oxidized low-density lipoprotein (oxLDL) play a central role in the initiation and progression of atherosclerotic lesions. In atherosclerotic lesions, oxLDL was also found to co-localize with beta2-glycoprotein I (beta2-GPI ...
Eiji, Matsuura, Kazuko, Kobayashi, Katsumi, Inoue, Yehuda, Shoenfeld   +3 more
openaire   +2 more sources

Intravenous Immunoglobulin and Fibrosis

Clinical Reviews in Allergy & Immunology, 2005
Fibrosis is a pathological process that includes scar formation and overproduction of extracellular matrix by the connective tissue as a response to tissue damage. Pathologies include pathological scarring as colloid and hypertrophic scars in the skin, cirrhosis of liver and gallbladder, pulmonary and bone-marrow fibrosis, and scleroderma.
Vered, Molina, Miri, Blank, Yehuda, Shoenfeld   +2 more
openaire   +2 more sources

Therapeutic intravenous immunoglobulins

Molecular Immunology, 2005
Intravenous immunoglobulins (IVIg) are concentrated formulations of human IgG prepared by industrial fractionation of large pools of individual plasma donations. IVIg were developed 20 years ago for the prophylaxis support of immunodeficient patients.
Réal, Lemieux, Renée, Bazin, Sonia, Néron   +2 more
openaire   +2 more sources

Immunomodulation by Intravenous Immunoglobulin

Journal of Pediatric Hematology/Oncology, 1990
In 1980, it was observed in a child with idiopathic thrombocytopenic purpura (ITP) that intravenous administration of pooled human immunoglobulin-G (IVIG) was followed by a rapid increase of the platelet count. Prompted by this finding, a pilot study and two prospective multicenter studies on children with ITP were organized.
P, Imbach, S, Barandun, H, Cottier, E, Gugler, A, Hassig, A, Morell, H, Wagner, H, Heiniger   +7 more
openaire   +2 more sources

Intravenous immunoglobulin

Clinical Immunology and Immunopathology, 1986
The development of immunoglobulin preparations suitable for intravenous use that are safe, acceptable, and efficacious represents a major advance in the treatment of immunodeficient patients. Experience in the United States and elsewhere in the world indicates that the benefits of use in patients with well-documented humoral immunodeficiency far ...
openaire   +2 more sources

Phannacokinetics of Intravenous Immunoglobulin in Neonates

Vox Sanguinis, 1989
Abstract. Intravenous immunoglobulin (IVIG) may be a therapeutic adjunct to antibiotic treatment of neonatal infections. We examined the pharmacokinetics and safety of IVIG in human neonates. Thirty neonates with suspected sepsis were randomly assigned either to a treatment (receiving either 250, 500, or 1,000 mg/kg of IVIG plus antibiotics) or ...
L E, Weisman, G W, Fischer, P, Marinelli, V G, Hemming, J R, Pierce, S M, Golden, C C, Peck   +6 more
openaire   +2 more sources

Immunomodulation With Intravenous Immunoglobulin

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1993
Since its introduction over a decade ago for the treatment of primary immunodeficiencies, intravenous immunoglobulin (IVIG) has demonstrated activity in a variety of autoimmune disorders. An understanding of IVIG's immunomodulatory effects provides the rationale for its potential application in the management of autoimmune disorders.
openaire   +2 more sources

Suppression of immunoglobulin production of lymphocytes by intravenous immunoglobulin

Journal of Clinical Immunology, 1991
The proliferative responses and the immunoglobulin production of peripheral blood mononuclear cells to pokeweed mitogen were dose-dependently suppressed by sulfonated intravenous immunoglobulin (IVIG), polyethylene glycol-treated IVIG, pH 4-treated IVIG, or human gamma-globulin, but they were not or only slightly suppressed by human serum albumin or ...
N, Kondo, T, Ozawa, K, Mushiake, F, Motoyoshi, T, Kameyama, K, Kasahara, H, Kaneko, M, Yamashina, Y, Kato, T, Orii   +9 more
openaire   +2 more sources